Changes in serum testosterone and estradiol concentrations following acute androstenedione ingestion in young women.
The effect of androstenedione intake on serum hormone concentrations in women is equivocal. Therefore, we examined the hormonal response to androstenedione intake in healthy young (22.1 +/- 0.4 y) women for 4 hours. On day 3 of the follicular phase, subjects ingested placebo, 100, or 300 mg androstenedione in a random, double-blind, cross-over manner. Blood samples were collected before and every 30 min for 240 min after intake. Serum androstenedione concentrations (means +/- SE) increased above basal (6.2 +/- 0.8 nmol/l) from 60-240 min for both 100 mg (22.6 +/- 1.0 nmol/l at 240 min) and 300 mg (28.1 +/- 1.3 nmol/l at 210 min). Androstenedione intake increased serum total testosterone concentrations above basal (1.2 +/- 0.2 nmol/l) from 120-240 min (5.5 +/- 0.9 nmol/l at 210 min) with 100 mg and from 60-240 with 300 mg (10.2 +/- 1.6 nmol/l at 210 min). Androstenedione intake also increased serum estradiol concentrations (basal 191 +/- 24 pmol/l) at 150 min with 100 mg (237 +/- 35 pmol/l) and from 150-240 min with 300 mg (reaching 260 +/- 32 pmol/l at 240 min). These data indicate that, in contrast to men, androstenedione intake in women increases serum testosterone concentrations.
Exercise Biochemistry Laboratory, Department of Health and Human Performance, Iowa State University, Ames, IA 50011, USA.
G A
GA
Brown
J C
JC
Dewey
J A
JA
Brunkhorst
M D
MD
Vukovich
D S
DS
King
D000328:Adult; D000735:Androstenedione / Q000008:administration & dosage* / Q000097:blood; D018592:Cross-Over Studies; D004032:Diet; D004311:Double-Blind Method; D002149:Energy Intake; D004958:Estradiol / Q000097:blood*; D015444:Exercise; D005260:Female; D005498:Follicular Phase; D006801:Humans; D007700:Kinetics; D010919:Placebos; D013739:Testosterone / Q000097:blood*
D010919:Placebos; D013739:Testosterone; D000735:Androstenedione; D004958:Estradiol